Latest News for: roches

Edit

Cancer Immunotherapies Market SWOT Analysis by Key Players Amgen, AstraZeneca, Roche

MENA FN 16 Oct 2021
(MENAFN - iCrowdNewsWire) HTF MI introduce new research on Global Cancer Immunotherapies covering micro level of analysis by competitors and key business segments. The Global Cancer Immunotherapies ... .
Edit

Wildcats, Roche, steamroll past Field Hockey team

Daily Times Chronicle 16 Oct 2021
Wilmington paid a visit, Tuesday night, and trampled all over that Redmen home field advantage thing, getting five goals from senior Rita Roche in a 6-0 non-league triumph ... The Wildcats kept on coming in the second quarter, resulting with the first goal for Roche ... She turned and passed to Roche, who fired the ball in for a 2-0 lead.
Edit

Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care (Roche Holding AG)

Public Technologies 15 Oct 2021
) Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care ... Builds on Roche's Digital Pathology Open Environment, expanding the company's commitment to improving patient outcomes and advancing personalised healthcare through innovation. Basel, 15 October 2021 - Roche (SIX.
Edit

US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer (Roche Holding AG)

Public Technologies 15 Oct 2021
) US FDA approves Roche's Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer ... Basel, 15 October 2021 - Roche (SIX ... About Roche in cancer immunotherapy ... To learn more about Roche's scientific-led approach to cancer immunotherapy, please follow this link. ... About Roche ... For more information, please visit www.roche.com.
Edit

New four-year data show Roche's ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder (Roche Holding AG)

Public Technologies 14 Oct 2021
) Basel, 14 October 2021 - Roche (SIX. RO, ROG; OTCQX ... Attachments Original document Permalink. Disclaimer. Roche Holding AG published this content on 14 October 2021 and is solely responsible for the information contained therein ... (noodl. 59120062) .
Edit

Invitation to Roche’s Virtual Event "Digitalization along the value chain" (Roche Holding AG)

Public Technologies 14 Oct 2021
Invitation to Roche's Virtual Event "Digitalization along the value chain" ... 17 November 2021, highlighting Roche's development in digital technology, data and advanced analytics ... Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com ... Roche Investor Relations.
Edit

Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or ...

MENA FN 14 Oct 2021
(MENAFN - GlobeNewsWire - Nasdaq) Short duration infusion of Gazyvaro– (obinutuzumab) is administered with a target infusion time of 90 minutes, compared to the current standard infusion time ... .
Edit

New four-year data show Roche' s ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis ...

MENA FN 14 Oct 2021
(MENAFN - GlobeNewsWire - Nasdaq) New data demonstrate ENSPRYNG's r obust and sustained longer-term efficacy in preventing relapses in people with neuromyelitis optica spectrum disorder ... .
Edit

DiRT3 - Battle in Luceram - Col St Roch | Route des Anges | Baroque ...

Bitchute 14 Oct 2021
Go to the source via the article link to view the video ....
Edit

Healthcare Nanotechnology (Nanomedicine) Market 2021 Research and Clinical Analysis - Amgen, Teva Pharmaceuticals, Abbott, UCB, Roche

MENA FN 14 Oct 2021
(MENAFN - Ameliorate Solutions) The– Healthcare Nanotechnology (Nanomedicine) – Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry ... .
Edit

New four-year data show Roche's ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica ...

Nasdaq Globe Newswire 14 Oct 2021
Basel, 14 October 2021 – Roche (SIX. RO, ROG; OTCQX. RHHBY) today announced new longer-term efficacy and safety data for ENSPRYNG® (satralizumab) ... .
×